BIAS-2015

BIAS-2015 categorizes germline genomic variants according to the ACMG classification system by evaluating 18 of the 28 ACMG criteria in an automated and consistent manner while recording the rationale for each classifier.

Key Features:

• Automated ACMG Classification: Evaluates 18 of the 28 ACMG criteria to classify variants into benign, likely benign, uncertain significance, likely pathogenic, or pathogenic categories.
• Rationale Recording: Records the rationale for each classifier to enable in-depth review of classification decisions.
• ClinGen Evidence Repository Integration: Leverages the ClinGen Evidence Repository for evaluation of variant classifications.

Scientific Applications:

• Germline Variant Interpretation: Automates the interpretation and classification of germline genomic variants according to ACMG/AMP guidelines.
• Clinical Genetic Testing Benchmarking: Performance can be evaluated against FDA-recognized human genetic variant databases such as the ClinGen Evidence Repository.

Methodology:

BIAS-2015 implements the ACMG/AMP 2015 guidelines as a complete open-source algorithm; specific computational steps for each of the 18 evaluated criteria are not detailed in the sources.